auto_awesome
Want to know who else bid on this?
Proposal Forge correlates this contract with the original RFP, the losing bidders, and the next recompete window.
Purpose
This project will support the development of Canada’s medical countermeasures (MCMs) in immediate response to COVID-19. Variation Biotechnologies Inc. (VBI) will advance the development of an enveloped Virus-Like-Particle (eVLP) vaccine candidate through clinical trials to provide protection against SARS-COV2 (COVID-19), MERS and SARS.
VBI Vaccines (Ontario Business Name Registration 260905344) × Innovation, Science and Economic Development Canada
3 grants totalling $167.9M
SIF Stream2- Growth
63 grants totalling $4.5B
Related Grants
| Recipient | Amount | Program |
|---|---|---|
| ArcelorMittal Dofasco G.P. | $450.0M | SIF Stream2- Growth |
| ArcelorMittal Dofasco G.P. | $450.0M | SIF Stream2- Growth |
| ArcelorMittal Dofasco G.P. | $400.0M | SIF Stream2- Growth |
| Air Products Canada LTD | $300.0M | SIF Stream2- Growth |
| Algoma Steel Inc. | $200.0M | SIF Stream2- Growth |